JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
-5.9%/yr
vs -2.8%/yr prior
5Y CAGR
-11.0%/yr
Recent acceleration
Acceleration
-3.1pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.48% | +22.4% |
| 2024 | 11.84% | +15.0% |
| 2023 | 10.29% | -40.8% |
| 2022 | 17.39% | -27.7% |
| 2021 | 24.07% | -7.1% |
| 2020 | 25.91% | +41.8% |
| 2019 | 18.27% | -6.2% |
| 2018 | 19.47% | -12.5% |
| 2017 | 22.26% | +9.2% |
| 2016 | 20.39% | - |